Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2024)

Benitec Biopharma (BNTC) has 6 years of Other Operating Expenses data on file, last reported at -$3000.0 in Q1 2024.

• For the quarter ending Q1 2024, Other Operating Expenses changed N/A year-over-year to -$3000.0; the trailing twelve-month figure through Dec 2024 stood at -$3000.0 (up 97.14% YoY), and the FY2024 full-year result was -$108000.0, changed N/A from the prior year.
• Other Operating Expenses slipped to -$3000.0 in Q1 2024, from $1000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $134000.0 in Q3 2020 to a low of -$106000.0 in Q3 2023.
• A 5-year average of $11900.0 and a median of $4000.0 in 2021 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses plunged 97.92% in 2021 and surged 800.0% in 2022, its largest moves.
• Tracing BNTC's Other Operating Expenses over 5 years: stood at -$19000.0 in 2020, then jumped by 105.26% to $1000.0 in 2021, then surged by 800.0% to $9000.0 in 2022, then sank by 88.89% to $1000.0 in 2023, then sank by 400.0% to -$3000.0 in 2024.
• Business Quant data shows BNTC's Other Operating Expenses at -$3000.0 in Q1 2024, $1000.0 in Q4 2023, and -$106000.0 in Q3 2023.